UC Santa Cruz Spinout ClaretBio Pursues NGS Sample Prep Market With Focus on cfDNA, FFPE
Jun 27, 2022 | Andrew P. Han
NEW YORK – Claret Bioscience is seeking to improve sample preparation for next-generation sequencing and cell-free DNA analysis. Recently, the firm won a $224,396 Small Business Innovation Research award from the National Human Genome Research Institute to develop a method for combined DNA and RNA sequencing from the same sample. The award is the third for the spinout from Richard Green's lab at the University of California, Santa Cruz. The firm also won two other SBIR grants, worth about $250,000 each, from the National Cancer Institute to develop a single-stranded library preparation protocol for cell-free DNA and to study degradation of cell-free DNA.
Read more here